Global Male Infertility Market Size To Worth USD 5.34 Billion By 2033 | CAGR of 3.49% [Yahoo! Finance]
Aytu BioPharma, Inc. (AYTU)
NASDAQ:AMEX Investor Relations:
aytubio.com/investors/stock-information
Company Research
Source: Yahoo! Finance
USD 5.34 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: Bayer Healthcare, Andrology Solutions, Endo International plc., Parallabs Ltd., MERCK KGaA, Aytu BioScience, Inc., Cadila Healthcare Ltd., Halotech DNA SL, EMD Sereno, Inc., Zydus Lifesciences Limited, Cryolab Ltd., Sanofi, SCSA Diagnostics, Inc., Vitrolife, Intas Pharmaceuticals Ltd., and Other key vendors. New York, United States, April 18, 2024 (GLOBE NEWSWIRE) -- The Global Male Infertility Market Size is to Grow from USD 3.79 Billion in 2023 to USD 5.34 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 3.49% during projected period. Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/4046 Male infertility is a disorder in which a guy is unable to conceive a female partner due to issues with his reproductive system. It is frequently associated with issues with sperm production, quality, and delivery. According to the worl
Show less
Read more
Impact Snapshot
Event Time:
AYTU
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AYTU alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AYTU alerts
High impacting Aytu BioPharma, Inc. news events
Weekly update
A roundup of the hottest topics
AYTU
News
- Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024 [Yahoo! Finance]Yahoo! Finance
- Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024Accesswire
- Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter [Yahoo! Finance]Yahoo! Finance
- Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second QuarterAccesswire
AYTU
Sec Filings
- 4/2/24 - Form 4
- 2/14/24 - Form 8-K
- 2/14/24 - Form 10-Q
- AYTU's page on the SEC website